Pharmaceuticals for the treatment of anxiety, including post-traumatic stress disorder, epilepsy, schizophrenia and other psychiatric disorders, chronic and neuropathic pain, neurodegenerative disorders, tumors, diabetes, movement disorders and anti-spastic treatment, drug abuse, including withdrawal treatment, COVID-19 related lung inflammation, oxidative stress, and skin diseases; none of the foregoing comprised of Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) content of more ...